Search Results - Fujishima, Yukiteru

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes

    Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes by Murai, Kazunori, Kowata, Shugo, Shimoyama, Tadashi, Yashima-Abo, Akiko, Fujishima, Yukiteru, Ito, Shigeki, Ishida, Yoji

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study

    Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study by Oyake, Tatsuo, Takemasa-Fujisawa, Yuka, Sugawara, Norifumi, Mine, Takahiro, Tsukushi, Yasuhiko, Hanamura, Ichiro, Fujishima, Yukiteru, Aoki, Yusei, Kowata, Shugo, Ito, Shigeki, Ishida, Yoji

    Published in Annals of hematology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Dasatinib Is Effective in the Treatment of Mice Models with Immune Thrombocytopenia

    Dasatinib Is Effective in the Treatment of Mice Models with Immune Thrombocytopenia by Shimoyama, Tadashi, Okano, Yoshiaki, Fujishima, Yukiteru, Oyake, Tatsuo, Kowata, Shugo, Murai, Kazunori, Ito, Shigeki, Ishida, Yoji

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Dasatinib Induced Thrombocytopenia Might Be Due To The Inhibition Of Proplatelet Formation Of Megakaryocytes Via The Pathways Including Rho/Rock and Rac

    Dasatinib Induced Thrombocytopenia Might Be Due To The Inhibition Of Proplatelet Formation Of Megakaryocytes Via The Pathways Including Rho/Rock and Rac by Murai, Kazunori, Kowata, Shugo, Fujishima, Yukiteru, Tsukushi, Yasuhiko, Mine, Takahiro, Oyake, Tatsuo, Ito, Shigeki, Ishida, Yoji

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections

    Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections by Oyake, Tatsuo, Masuda, Takayuki, Sugawara, Norifumi, Asahi, Maki, Suzuki, Yuzo, Okano, Yoshiaki, Fujishima, Yukiteru, Aoki, Yusei, Kowata, Shugo, Ito, Shigeki, Ishida, Yoji

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial

    Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial by Oyake, Tatsuo, Fujisawa, Yuka, Sugawara, Norifumi, Sasaki, Ryousei, Izumita, Wataru, Mine, Takahiro, Asahi, Maki, Suzuki, Yuzo, Okano, Yoshiaki, Fujishima, Yukiteru, Tsukushi, Yasuhiko, Aoki, Yusei, Kowata, Shugo, Hanamura, Ichiro, Murai, Kazunori, Ito, Shigeki, Ishida, Yoji

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

    Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial by Oyake, Tatsuo, Fujisawa, Yuka, Sugawara, Norifumi, Nakagawa, Yasunori, Mine, Takahiro, Hanamura, Ichiro, Asahi, Maki, Fujishima, Yukiteru, Aoki, Yusei, Kowata, Shugo, Ito, Shigeki, Ishida, Yoji

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Ponatinib Induced Thrombocytopenia Might Inhibit Proplatelet Formation of Megakaryocytes Via the Pathways Including Rho/Rock and Rac

    Ponatinib Induced Thrombocytopenia Might Inhibit Proplatelet Formation of Megakaryocytes Via the Pathways Including Rho/Rock and Rac by Murai, Kazunori, Kowata, Shugo, Oyake, Tatsuo, Shimoyama, Tadashi, Asahi, Maki, Norifumi, Sugawara, Sasaki, Ryosei, Yuzo, Suzuki, Yukiteru, Fujishima, Tsukushi, Yasuhiko, Ito, Shigeki, Ishida, Yoji

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Crystal Structure of Basic Fibroblast Growth Factor at 1.6 Å Resolution

    Crystal Structure of Basic Fibroblast Growth Factor at 1.6 Å Resolution by Ago, Hideo, Kitagawa, Yasuyuki, Fujishima, Akira, Matsuura, Yoshiki, Katsube, Yukiteru

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: